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Virus-induced leukemogenesis in mice was first described by Gross (1,  2)  in 
studies in which the successful transmission of leukemia (thymic lymphoma) by 
cell-free extracts from AKR thymomas depended on the inoculation of newborn 
C3H/Bi mice. Serial passage of this virus resulted in the potent Gross passage A 
virus  (2).  Although a  very high percentage of newborn  mice inoculated with 
Gross virus (GV) develop thymic lymphomas, adult mice are resistant to the virus 
and develop no disease. No reason for this susceptibility of neonates has been 
determined, however, it appears likely that it is related to either (a) an effect on 
the immature immune system of the neonate or (b) the presence of certain target 
precursor or stem cells that are not present in the adult. 
Resistance to murine leukemia virus (MuLV)-induced disease is mediated by 
several genes (3).  Lilly found that when mice expressing various 1-1-2 haplotypes 
were  inoculated  with  high  doses  of virus,  all  mice  regardless  of hapiotype 
developed iymphomas. However, when low doses were used, homozygous H-2 k 
mice were susceptible to disease, whereas homozygous H-2 b mice were resistant 
(4,  5).  Backcross  analysis and  the  use  of mice  with  recombinant  haplotypes 
determined that a gene, Rgv-1, linked to the H-2K region controlled this relative 
resistance to GV-induced disease. 
We have identified an apparently new variant of Gross passage A  virus that 
causes thymic lymphomas in mice inoculated intraperitoneally (i.p.) as adults. In 
addition, pathogenesis induced by high doses of  this virus is very closely regulated 
by a gene(s) linked to the 1-1-2 complex. 
Materials and Methods 
Mice.  C57BL/10Li  (B10/Li),  BALB/c-H-2 k  (BALB.K/Li),  and  BALB/c-H-2  b 
(BALB.B/Li) mice were bred from pairs obtained from Dr. Frank Lilly, Albert Einstein 
College of Medicine, Bronx,  NY.  C57BL/10-H-2  k (B10.K) mice were bred from pairs 
obtained from Dr. Donald Shreffler, University of Washington, St. Louis, MO. 
Virus.  The Gross virus variant used in these studies is derived from BALB/c-adapted 
GV originally obtained from Dr.  Frank Lilly. Briefly, this virus is maintained  by serial 
passage in  BALB mice inoculated  as  neonates.  Virus  stocks are  prepared  from  10% 
homogenates  in Hanks Balanced Salt Solution (HBSS) of the greatly enlarged thymus, 
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spleen, and lymph nodes of suceptible mice inoculated with a high dose of virus. These 
homogenates kept continuously at 0-4°C, were clarified by centrifugation for 15 min at 
2,400 g. The virus supernatants were stored in 2-ml ampules at -70°C until used. 
Cytotoxicit,~,.  The expression  of Thy-1, Gross cell surface antigen (GCSA) and  Ia  on 
cultured tumor cell lines derived from thymic lymphomas  was examined by trypan blue 
exclusion  in an antibody and complement-mediated cytotoxicity assay. Briefly,  105 cells 
were incubated with antibody in 0.2 ml medium (RPMI 1640 with  10% fetal calf serum) 
at room temperature for 30 min. The cells were centrifuged, washed in fresh medium, 
and incubated with guinea pig complement (1:4) for 40 min at 37°C.  After complement 
treatment,  the cells were examined for viability by trypan blue exclusion.  Testing for 
Thy-1  and  Ia.2  expression  was  performed  by direct  cytotoxicity.  Testing  for  GCSA 
expression  was performed by absorption of anti-GCSA  antiserum with various  cell lines 
(see Table III) and subsequent testing of the absorbed antiserum for residual anti-GCSA 
activity by direct cytotoxicity on the Ed Gross (GCSA  +) tumor cells. C57BL/6 anti-K36 
antiserum,  which  detects GCSA, was kindly  supplied  by Dr.  Elizabeth  Stockert, Sloan- 
Kettering Institute for Cancer Research,  New York, NY. Monoclonal antibodies detecting 
Thy-l.2 and Ia.2 were kindly supplied by Dr. Jonathan Sprent, University of Pennsylvania 
School of Medicine, Philadelphia,  PA. 
Results 
Adult  8-wk  old  BALB.K  mice  were  inoculated  i.p.  with  BALB/c-adapted 
Gross virus that  previously had only induced thymic lymphomas in mice inocu- 
lated as neonates.  5 mo later, these mice were found to have developed greatly 
enlarged thymuses and spleens. A cell-free virus stock was prepared from these 
thymuses by passing homogenates through a 0.20-#m filter. The virus was serially 
passaged through  BALB.K mice twice. This procedure resulted in an apparent 
increase in virus potency since the latent period for thymoma development was 
reduced to 6-8 wk. We have tentatively assigned the designation  WB91-GV to 
this virus. 
H-2-Li~ked Resista~ce to WB91-GV.  10-12-wk old mice congenic with respect 
to their H-2 haplotypes were compared for susceptibility to WB91-GV-induced 
leukemogenesis (Table I). B 10/Li (H-2 b) mice appeared to be absolutely resistant 
to  WB91-GV  since  no  mice  (0/12)  showed  any  signs  of disease  6  mo  after 
inoculation.  In contrast 86% (13/15) of congenic B10.K (H-2  k) mice developed 
thymomas. In a similar manner,  91% (11/12) of BALB.K mice inoculated with 
WB91-GV developed thymomas, whereas only 12% (3/26) of congenic BALB.B 
(H-2 b) mice developed disease after 6 mo. Sublethally irradiated (500 R) BALB.B 
mice all developed thymic lymphomas after virus inoculation. 
The  disease  found  in  the  few normal  BALB.B mice  that  developed disease 
differed significantly from that found in BALB.K mice. In BALB.K mice, both 
the  thymus  and  peripheral  lymphoid  organs  showed  leukemic  involvement, 
whereas unirradiated  BALB.B mice showed the typical thymic enlargement but 
no involvement of peripheral  lymphoid organs.  Irradiated  BALB.B mice, how- 
ever, showed the same profile of organ involvement as BALB.K mice. 
Growth of Syngeneic Transplanted  Tumor Cells.  As shown in Table II, syngeneic 
tumor  cells  (single  cell  suspensions),  derived  from  the  enlarged  thymuses  of 
donor mice, as well as cultured syngeneic tumor cells derived from WB91-GV 
infected  mice,  grew  well  in  normal  BALB.K  mice  as  well  as  in  sublethally 
irradiated  and  virus-infected recipients.  However, in  BALB.B mice,  which ex- 
press the H-2 b haplotype,  syngeneic tumor cells grew in  sublethally  irradiated WOLFE  AND  BLANK  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
H-2-Mediated Resistance to WB91-GV 
Thymoma 
Strain  H-2 Type  Treatment*  developments 
B10.K  k  None  13/15 
BALB.K  k  None  11 /  12 
BALB.K  k  450R  10/10 
B 10  b  None  0/12 
BALB.B  b  None  3/26 
BALB.B  b  450R  5/5 
* All animals were inoculated i.p. with 0.2  ml of a  10% homogenate of 
leukemic thymus and spleen containing ~2  x  104 PFU as measured in 
XC assay. Animals were irradiated 24 h before virus inoculation. 
* Animals were observed for 6  mo. Those that did not die from thymo- 
magenesis were autopsied and examined for signs of pathogenesis. 
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TABLE  II 
H-2-linked Resistance to Growth of Transplanted Syngeneic Tumor Cells Induced 
with WB91-GV 
Tumor growth ! 
Strain  H-2 Type  Treatment*  Cultured tumor 
1  ° Tumor cells  cells 
BALB.K  k  None  5/5  5/5 
BALB.K  k  500R*  5/5  5/5 
BALB.K  k  WB91 a  5/5  5/5 
BALB.B  b  None  0/5  0/5 
BALB.B  b  500R  4/5  5/5 
BALB.B  b  WB91  0/5  0/5 
B 10.K  k  None  0/5  0/5 
B10.K  k  500R  0/5  0/5 
B10.K  k  WB91  2/5  4/5 
* Recipients were inoculated subcutaneously with 5  ×  106 syngeneic tumor cells from 
the enlarged thymuses of adult mice inoculated with WB9 I-GV or 105 syngeneic cells 
from  cultured  tumor cell  lines derived from the enlarged thymuses of adult  mice 
inoculated with WB91-GV (see Table III). 
* Recipients were irradiated 24 h before tumor inoculation. 
0 Recipients were inoculated with WB91-GV 2 wk before tumor inoculation. 
I Recorded as number of mice in which tumor growth progressed/total inoculated. 
but not in WB91-GV-infected recipients, indicating that irradiation  may immu- 
nosuppress mice, allowing the growth of tumor cells. Surprisingly, both normal 
and irradiated  B10.K recipients rejected syngeneic tumor cells. The  failure of 
tumor cells to grow in irradiated  B10.K mice suggests that  some radioresistant 
immune  component  exists in  mice  with  a  B10 but not a  BALB genetic back- 
ground.  Only prior  inoculation  of B10.K mice with  WB91-GV allowed tumor 
growth to progress. 
Antigenic  Determinants  on  the  Tumor  Cell Surface.  Cultured  tumor  cell  lines 
have been derived from WB91-GV-induced thymic lymphomas of BALB.K and 
B10.K mice. Cells from these lines grow in suspension and, as shown in Table 
III,  express  GCSA  (Gross  cell  surface  antigen),  characteristic  of GV-infected 632  WOLFE  AND  BLANK  BRIEF  DEFINITIVE  REPORT 
TABLE  IlI 
Expression of Cell Su~lce Antigens on Virus-induced Tumor Cell Lines* 
Cell line 
Cytotoxic indices with:  § 
Strain of origin  Inducing 
virus*  Anti-GCSA i  Anti-  Anti-Ia.2  ~ 
+C  Thy-l.2 ~ +C  +C 
B10.K(WB91)-I  BI0.K  WB91  3  95  0 
BALB.K(WB91)-1  BALB.K  WB91  4  94  3.5 
HFL/b (Clone L)  BALB.B  FV  98  0  0 
BALB.B gv-I  BALB.B  GV  2  93  1 
Normal 
BALB.K lymph node  BALB.K  none  98  56  32 
* Assayed by two-step antibody and complement mediated cytotoxicity. See Materials and Methods. 
* WB91, Gross virus adult variant; FV,  Friend virus (N-->NB tropic; polycythemic); GV, Original 
(;ross virus stock. 
Cytotoxic indices were calculated as  100  ×  % killed (Ab +  C) -  % killed (C alone) 
100 -  % killed (C alone)  . Background 
lysis  with complement alone ranged from  0-12%.  Controls incubated with antibody alone were 
>95% viable. 
a Anti-GCSA antiserum was absorbed with cells from the appropriate cell line and tested for residual 
anti-GCSA activity on EC~ Gross (GCSA  +) tumor cells. 
Assayed with unabsorbed antiserum by direct cytotoxicity. 
cells,  and  Thy-l.2  but  do  not  express  Ia.2  as  determined  by  antibody  and 
complement-mediated  cytotoxicity. 
Discussion 
The  results of these studies appear  to indicate  that we have isolated a variant 
of Gross virus which,  unlike the original  virus, induces thymic iymphomas when 
inoculated  i.p.  into  adult  mice.  That  this  virus  is  a  variant  of GV  and  not  a 
completely  new  virus  is  suggested  by the  fact  that  (a)  tumor  cells  induced  in 
animals  inoculated  as adults express GCSA characteristic  of GV (Table  III) and 
(b)  the  profile  of  organ  involvement  is  the  same  as  that  observed  in  mice 
inoculated  with GV as neonates. 
In  our  studies  with  BALB mice,  there  appears  to  be a  correlation  between 
resistance  to  virus-induced  thymomagenesis  and  the ability  to reject  syngeneic 
tumor  cell  grafts,  i.e.,  BALB.K  mice  are  susceptible  to  virus and  fail  to reject 
transplanted  tumor  cells,  whereas  BALB.B  mice are  resistant  to  virus and  are 
resistant to the growth of tumor cell grafts (Tables I and II). In addition, BALB.B 
mice immunosuppressed  by irradiation  are both  susceptible to virus and fail  to 
reject  transplanted  tumor  cells  (Tables  I  and  II).  These  studies,  therefore, 
strongly  suggest  that  in  mice  with  a  BALB genetic  background,  H-2-mediated 
resistance  to WB91-GV  is regulated  by radiosensitive  immune  cells, most likely 
cytotoxic T  cells and/or  antibody-producing  B cells, which  can either  generate 
an  effective  anti-viral  immune  response  as  in  BALB.B  mice  or  cannot  as  in 
BALB.K mice.  In B10.K mice, however,  there  is a dissociation  between suscep- 
tibility to virus and the ability to reject syngeneic tumor cells, i.e.,  both normal 
and  irradiated  B10.K  mice  reject  syngeneic  tumor  grafts  (Table  II)  although 
untreated  B10.K  mice are  susceptible to virus (Table  I).  It,  therefore,  appears 
that  in  B10.K  mice  there  are  radioresistant  cells,  perhaps  NK  cells or  macro- WOLFE  AND  BLANK  BRIEF  DEFINITIVE  REPORT  633 
phages, that can effectively inhibit tumor cell growth. Transplanted tumor cells 
do  grow  in  B10.K  recipients  that  are  pretreated  with  WB91-GV  (Table  I) 
suggesting that virus expression and/or production in these mice may suppress 
their radioresistant immune cells.  Interestingly, this virus-induced suppression 
of tumor cell graft rejection is not observed in BALB.B mice pretreated with 
virus (Table  II).  A  likely explanation  for this  difference between B10.K  and 
BALB.B  mice may be  that  BALB.B  mice, by virtue of their H-2 h haplotype, 
eliminate replicating virus by mounting an effective anti-virus response, whereas 
B 10.K (H-2 k) may fail to generate this response. The consequence of this failure 
to respond could be the continued expression of virus in  B10.K  hosts,  which 
may then result in the suppression of cells responsible for tumor cell rejection. 
In  BALB.B  mice, however, with the virus cleared, tumor cell rejection could 
proceed effectively. It  is  possible  that  these events,  which may occur during 
tumor cell  graft rejection,  may also affect the process of thymomagenesis by 
controlling the generation of immune responses to autochthanous tumor cells in 
virus-infected mice. 
It is interesting to  note that a  few untreated BALB.B  mice develop thymic 
lymphomas (Table I) but there is no spread of malignant cells to the peripheral 
lymphoid organs as apparently occurs in BALB.K and irradiated BALB.B mice. 
This  finding may reflect the presence of immune cells in  the periphery that 
effectively eliminate tumor cells as they leave the thymus. 
The leukemogenic viruses isolated from AKR thymomas have been found to 
be dualtropic mink cell focus-forming (MCF) viruses (6, 7) although some appear 
to be ecotropic (8,  9).  These viruses contain gag,  pol,  and env  regions but  no 
transforming genes (9-11). In this respect, they are similar to avian leukosis virus 
(ALV), which induces B cell transformation in chickens, apparently by a  pro- 
moter-insertion mechanism in which the proviral genome integrates adjacent to 
c-mvc resulting in  the increased transcription of this gene (12-14).  Like ALV, 
MCF viruses have recently been shown to have a  common region of provirus 
integration (11). It has not yet been demonstrated whether some gene similar to 
c-myc, whose constitutive expression in T  cells might result in transformation, is 
located in  this region of MCF  proviral integration.  However, if this were the 
case, it is possible that in the long passage history of the BALB/c-adapted GV, 
this virus has acquired a  v-onc  from the cell genome which now acts as a  viral 
transforming gene similar to others previously described (see reference 15). Such 
an event might account for the potency of WB91-GV in adult animals. 
Alternatively, the leukemogenicity in adult mice of WB91-GV may be associ- 
ated with certain unique changes that have occurred in the 3'  (env-U3) region 
of the virus genome, either as the result of mutation or recombination with some 
endogenous virus.  Differences within this region have previously been demon- 
strated to affect the leukemogenicity and potency of retroviruses (9,  10). 
Summary 
Gross murine leukemia virus normally induces leukemia (thymic lymphoma) 
in mice inoculated as neonates, but not as adults. We have isolated an apparent 
variant of this virus which induces thymomas when inoculated i.p. into susceptible 
adult mice. Using H-2 congenic BALB and C57BL mice, susceptibility to virus- 634  WOLFE  AND  BLANK  BRIEF  DEFINITIVE REPORT 
induced thymomagenesis was found to be linked to the H-2 complex. In addition, 
a  radioresistant  immune mechanism leading to inhibition  of tumor growth was 
observed in mice with a  C57BL but not a  BALB background. 
We wish to thank Ms. Ellen Schwartz for her excellent secretarial assistance. 
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